Effects of micronised purified flavonoic fraction on microcirculation in women suffering from chronic venous disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN18841175

Enrollment

240

Registered

2009-08-19

Start date

2009-07-22

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic venous disease Circulatory System Other disorders of veins

Interventions

Micronised purified flavonoic fraction 500 mg over four menstrual cycles versus placebo.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 29/11/2012: 1. Female suffering from primary chronic venous disease 2. Aged 18 to 30 years old Previous inclusion criteria until 29/11/2012: 1. Female suffering from primary chronic venous disease 2. Aged 18 to 50 years old

Exclusion criteria

Exclusion criteria: 1. Patients with irregular menstrual cycles 2. Women of childbearing potential without effective contraception

Design outcomes

Primary

Measure	Time frame
Effects on microcirculatory and biological parameters over four menstrual cycles	—

Secondary

Measure	Time frame
Safety	—

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026